Professional Media briefs

Share this article:
VideoMD.com, launched in 2008 as a way for physicians to upload educational videos for patients, announced that it has now registered 2,500 physicians and healthcare practitioners. Physicians can create their own videos for the site, or choose videos from a catalog to educate their patients.

The Female Patient, a medical journal focused on OB/GYNs has partnered with Red Hot Mamas, a menopause education organization, to offer “The Buzz on Bioidenticals,” a multimedia program and webinar scheduled for August 4. The webinar will feature Karen Giblin, president and founder of Red Hot Mamas, and Elizabeth Lee Vliet, an author, radio show host and hormone therapy expert. The webinar will be accessible for free via registration at www.thebuzzonbios.com.

Scientific, technical and medical publisher Elsevier announced that Chris Dillion joined Elsevier Health Sciences as managing director for the clinical decision support (CDS) group. Dillon will be responsible for all CDS operations and strategy, including product development, marketing and sales. CDS is Elsevier's point-of-care, payer, provider and eLearning business unit.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?